In a recent news article by the OHRI, the uOBMRI’s Dr. Tiago Mestre is highlighted in an article on “Hope for Huntington’s: New gene-targeted therapy trial opens in Ottawa.”
This piece shines a light on how the innovative clinical trial of a gene target therapy is bringing new hope for people with Huntington’s disease of slowing down or even stopping the progression of the disease.